Device Trial Radar · NCT07324031
Parasternal Extravascular ICD System Pivotal Clinical Investigation (ALARION EV) Study
Last checked: Nov 19, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
280
Planned (sponsor's estimate)
Start
Jul 2, 2026
Primary completion
Aug 31, 2027
Study completion Dec 31, 2028
Sponsor
- Lead sponsor
- AtaCor Medical, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Jan 7, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The ALARION EV Study is a prospective, multi-center, single-arm, non-randomized study without concurrent or historical controls. The purpose of this pivotal study is to generate evidence of safety and effectiveness to apply for regulatory approvals for commercialization of the Parasternal EV-ICD System. The objective of the study is to demonstrate safety and effectiveness of the Parasternal EV-ICD System through 6-months.
Conditions
- Ventricular Arrythmia
- Ventricular Fibrillation
- Ventricular Tachycardia
Interventions
Atala™ lead and EV-ICD Pulse GeneratorDevice
Subjects will receive the Atala™ lead and EV-ICD pulse generator being evaluated in the study.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Freedom from MADEsTime frame: Through 6 months post-implant
- Successful IVA TestTime frame: At the time of procedure and up to 60 days post-implant
Locations
35 sites in 2 countries. Site status is shown where the registry gives one.
Honor Health
Scottsdale, Arizona · Not yet recruiting
St. Bernards Heart and Vascular
Jonesboro, Arkansas · Recruiting
UC San Diego Health
La Jolla, California · Not yet recruiting
32 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.